A BILL 
To amend title III of the Public Health Service Act to 
eliminate immunity for manufacturers of COVID–19 vac-
cines, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘COVID–19 Vaccine 
4
Accountability Act’’. 
5
SEC. 2. LIABILITY OF COVID–19 VACCINE MANUFACTURERS. 
6
(a) COVERED COUNTERMEASURE.—Section 319F– 
7
3(i)(1) of the Public Health Service Act (42 U.S.C. 247d– 
8
6d(i)(1)) is amended by adding at the end the following: 
9
16:58 Dec 21, 2021
H6282
2 
•HR 6282 IH
‘‘Such term does not include vaccines for 
1
COVID–19 that are required (directly or as a 
2
condition of employment, schooling, or other-
3
wise) under Federal, State, or local law to be 
4
administered to individuals eligible to receive 
5
such a vaccine.’’. 
6
(b) COVERED PERSON.—Section 319F–3(i)(2) of the 
7
Public Health Service Act (42 U.S.C. 247d–6d(i)(2)) is 
8
amended by adding at the end the following: 
9
‘‘Such term does not include a manufacturer of 
10
a vaccine described in the matter following sub-
11
paragraph (D) of paragraph (1).’’. 
12
(c) LIMITATION OF LIABILITY.—Section 319F–3 of 
13
the Public Health Service Act (42 U.S.C. 247d–6d) is 
14
amended by adding at the end the following: 
15
‘‘(j) LIMITATION ON LIABILITY.—Pursuant to, and 
16
consistent with, the sovereign immunity reservation speci-
17
fied in subsection (f), the liability of the United States 
18
for a death or injury caused by the administration of a 
19
vaccine for COVID–19 occurring on or after January 1, 
20
2020 shall not exceed $10,000.’’. 
21
Æ 
16:58 Dec 21, 2021
H6282
